263 related articles for article (PubMed ID: 9509038)
1. Surfactant and the neonatal lung.
Gibson AT
Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):381-4, 397. PubMed ID: 9509038
[TBL] [Abstract][Full Text] [Related]
2. [Drug treatments of respiratory distress syndrome in premature infants].
Saliba E; Laugier J
Pediatrie; 1993; 48(12):864-71. PubMed ID: 8047397
[TBL] [Abstract][Full Text] [Related]
3. Surfactant for respiratory distress syndrome: are there important clinical differences among preparations?
Sinha S; Moya F; Donn SM
Curr Opin Pediatr; 2007 Apr; 19(2):150-4. PubMed ID: 17496757
[TBL] [Abstract][Full Text] [Related]
4. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology.
Jobe A
Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946
[TBL] [Abstract][Full Text] [Related]
5. Untapped therapeutic potential of surfactant proteins: is there a case for recombinant SP-D supplementation in neonatal lung disease?
Clark HW
Neonatology; 2010 Jun; 97(4):380-7. PubMed ID: 20551708
[TBL] [Abstract][Full Text] [Related]
6. Surfactant respiratory therapy using Surfaxin/sinapultide.
Lal MK; Sinha SK
Ther Adv Respir Dis; 2008 Oct; 2(5):339-44. PubMed ID: 19124381
[TBL] [Abstract][Full Text] [Related]
7. Economic consequences of surfactant therapy.
Eidelman AI
J Perinatol; 1993; 13(2):137-9. PubMed ID: 8515307
[No Abstract] [Full Text] [Related]
8. Synthetic surfactant.
Long W
Semin Perinatol; 1993 Aug; 17(4):275-84. PubMed ID: 8140442
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
Ghaemi S; Mohamadymasodi M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
[TBL] [Abstract][Full Text] [Related]
10. Surfactant replacement therapy: impact on hospital charges for premature infants with respiratory distress syndrome.
Maniscalco WM; Kendig JW; Shapiro DL
Pediatrics; 1989 Jan; 83(1):1-6. PubMed ID: 2909956
[TBL] [Abstract][Full Text] [Related]
11. Exogenous surfactant therapy: newer developments.
Lacaze-Masmonteil T
Semin Neonatol; 2003 Dec; 8(6):433-40. PubMed ID: 15001115
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of prevention and treatment of neonatal respiratory distress (RDS) with exogenous surfactant: what has changed in the last three decades?
Mugford M
Early Hum Dev; 2006 Feb; 82(2):105-15. PubMed ID: 16457971
[TBL] [Abstract][Full Text] [Related]
13. Death postponement and increased chronic lung disease: the hidden costs of mortality reduction in the post-surfactant era.
Wright K
J Assoc Acad Minor Phys; 1999; 10(4):82-7. PubMed ID: 10826014
[TBL] [Abstract][Full Text] [Related]
14. Surfactant replacement therapy for respiratory distress syndrome. American Academy of Pediatrics. Committee on Fetus and Newborn.
Pediatrics; 1999 Mar; 103(3):684-5. PubMed ID: 10049980
[TBL] [Abstract][Full Text] [Related]
15. [Exogenous surfactant therapy: new synthetic surfactants].
Lacaze-Masmonteil T
Arch Pediatr; 2008 Jun; 15 Suppl 1():S42-6. PubMed ID: 18822258
[TBL] [Abstract][Full Text] [Related]
16. Impact of surfactant treatment on cost of neonatal intensive care: a cost-benefit analysis.
Merritt TA; Hallman M; Vaucher Y; McFeeley E; Tubman TR
J Perinatol; 1990 Dec; 10(4):416-9. PubMed ID: 2126034
[No Abstract] [Full Text] [Related]
17. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
[TBL] [Abstract][Full Text] [Related]
18. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
Wirbelauer J; Speer CP
J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
[TBL] [Abstract][Full Text] [Related]
19. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
Engle WA;
Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
[TBL] [Abstract][Full Text] [Related]
20. [Factors affecting clinical response to surfactant therapy in neonates with severe respiratory distress syndrome].
Fujiwara T; Chida S; Konishi M
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):29-34. PubMed ID: 2041254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
